Tag: Elivaldogene autotemcel

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Elivaldogene autotemcel

bluebird bio (NASDAQ:BLUE) Rating Lowered to Neutral at JPMorgan Chase & Co.

Added to Collection on: 2024-08-16 03:43:54

Tags for this article:

Orphan drugs
Equity securities
Bluebird bio
Stock market
Elivaldogene autotemcel
Betibeglogene autotemcel
Berkshire Hathaway
Stock
Michael Burry
Meta Platforms
NASDAQ
Hedge fund
Bluebird Bio Inc

Click the tags to see associated articles and topics

View Article Details
Analysts Set bluebird bio, Inc. (NASDAQ:BLUE) PT at $5.46 - Defense World

Added to Collection on: 2024-08-18 17:26:13

Tags for this article:

Orphan drugs
Biotechnology
Gene delivery
Stock market
Bluebird bio
Equity securities
Elivaldogene autotemcel
Betibeglogene autotemcel
Overweight
Short
Gene therapy
Share

Click the tags to see associated articles and topics

View Article Details
Gene Therapy Shows Long-Term Benefit for Patients with a Rare Pediatric Brain Disease

Added to Collection on: 2024-10-09 21:50:03

Tags for this article:

Gene delivery
Rare diseases
Applied genetics
Molecular genetics
Orphan drugs
Elivaldogene autotemcel
Bluebird bio
Gene therapy
Adrenoleukodystrophy
Lentiviral vector in gene therapy
Leukodystrophy
Viral vector

Click the tags to see associated articles and topics

View Article Details
Book a Demo